摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 6-(2-(4-methylpyridin-2-yl)-1H-benzoimidazol-1-yl)hexylcarbamate | 1418131-04-0

中文名称
——
中文别名
——
英文名称
tert-butyl 6-(2-(4-methylpyridin-2-yl)-1H-benzoimidazol-1-yl)hexylcarbamate
英文别名
——
tert-butyl 6-(2-(4-methylpyridin-2-yl)-1H-benzoimidazol-1-yl)hexylcarbamate化学式
CAS
1418131-04-0
化学式
C24H32N4O2
mdl
——
分子量
408.544
InChiKey
WAVKTSRMLIPZAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.49
  • 重原子数:
    30.0
  • 可旋转键数:
    8.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    69.04
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    ammonium hexafluorophosphate 、 顺-双(2,2-二吡啶)二氯化钌(II) 水合物tert-butyl 6-(2-(4-methylpyridin-2-yl)-1H-benzoimidazol-1-yl)hexylcarbamate乙二醇 为溶剂, 反应 6.0h, 以72%的产率得到[Ru(II) bis(2,2'-bipyridine){6-[2-(4-methylpyridin-2-yl)-1H-benzoimidazol-1-yl]hexylamine}](PF6)2
    参考文献:
    名称:
    Ruthenium polypyridyl squalene derivative: A novel self-assembling lipophilic probe for cellular imaging
    摘要:
    Transition metal complexes provide a promising avenue for designing new therapeutic and diagnostic agents. In particular, ruthenium(II) polypyridyl complexes are useful for studying cellular uptake, due to their easy synthesis and unique photophysical properties. Dyes are frequently combined with material substrates to modulate their properties, enhance stability, reduce toxicity, and improve delivery. A novel Ru polypyridyl complex linked to a derivative of the natural lipid squalene (Ru-BIPPBI-hx-SQ) is described. Using the solvent displacement method, Ru-BIPPBI-hx-SQ easily self-assembles into nanosized aggregates in aqueous solution, as characterized by dynamic light scattering. The nanoassemblies exhibit long-lived and intense luminescence. Preliminary biological assessment showed them to be non-toxic; they are efficiently and rapidly transported across the cell membrane without requiring its permeabilization. Ru-labeled nanoassemblies are likely to be significant cellular-imaging tools, probing cellular events at very low concentrations. Moreover co-nanoassembly, with drug-derivatives based on squalenoylation technology, including gemcitabine and paclitaxel, has given interesting preliminary results. (c) 2012 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ijpharm.2012.07.022
  • 作为产物:
    描述:
    N-BOC-6-溴代己胺4-甲基-2-(2-苯并咪唑基)吡啶potassium tert-butylate 作用下, 以 乙醚N,N-二甲基甲酰胺 为溶剂, 反应 8.25h, 以75%的产率得到tert-butyl 6-(2-(4-methylpyridin-2-yl)-1H-benzoimidazol-1-yl)hexylcarbamate
    参考文献:
    名称:
    Ruthenium polypyridyl squalene derivative: A novel self-assembling lipophilic probe for cellular imaging
    摘要:
    Transition metal complexes provide a promising avenue for designing new therapeutic and diagnostic agents. In particular, ruthenium(II) polypyridyl complexes are useful for studying cellular uptake, due to their easy synthesis and unique photophysical properties. Dyes are frequently combined with material substrates to modulate their properties, enhance stability, reduce toxicity, and improve delivery. A novel Ru polypyridyl complex linked to a derivative of the natural lipid squalene (Ru-BIPPBI-hx-SQ) is described. Using the solvent displacement method, Ru-BIPPBI-hx-SQ easily self-assembles into nanosized aggregates in aqueous solution, as characterized by dynamic light scattering. The nanoassemblies exhibit long-lived and intense luminescence. Preliminary biological assessment showed them to be non-toxic; they are efficiently and rapidly transported across the cell membrane without requiring its permeabilization. Ru-labeled nanoassemblies are likely to be significant cellular-imaging tools, probing cellular events at very low concentrations. Moreover co-nanoassembly, with drug-derivatives based on squalenoylation technology, including gemcitabine and paclitaxel, has given interesting preliminary results. (c) 2012 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ijpharm.2012.07.022
点击查看最新优质反应信息